With flu, respiratory syncytial virus (RSV), and COVID-19 cases starting to rise, officials say now is the time to get a ...

About The Study: In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of ...

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase ...

Health chiefs fear people from parts of Birmingham will end up in hospital due to a lack of uptake of flu jabs. Last week, ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory Syncytial Virus (RSV), and these low ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Respiratory syncytial virus, or RSV, is a virus that causes infections of the lungs and breathing passages. It is highly ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...